The Board of OncoSil Medical Ltd. announced that Mr. Nigel Lange has been appointed as Chief Executive Officer and Managing Director of the Company, effective 21 January 2021. Nigel joined the Company in May 2020 as EMEA President, bringing with him over 30 years of experience in the medical devices industry. Since 2003, Nigel has held various leadership roles with Sirtex Medical, a global leader in brachytherapy treatment for liver cancer. From 2003, Nigel served as Chief Executive Officer of Sirtex's European business, responsible for establishing their brachytherapy device in over 300 centres across Europe and Middle East. Since 2017, Nigel served as Group Chief Commercial Officer where he was responsible for all commercial aspects of the global business. During this time, Nigel has also held interim roles including Interim Group CEO and Interim CEO of Asia Pacific. Nigel will be located in Berlin, Germany as the Company focuses on the commercialization of the OncoSil device following CE Mark approval last year. Nigel will continue with his responsibilities as President EMEA following his appointment as CEO and Managing Director.